| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal double-negative T cell morphology | 2.75e-05 | 112 | 74 | 6 | MP:0002407 | |
| MousePheno | absent B cells | 4.97e-05 | 14 | 74 | 3 | MP:0008071 | |
| Domain | MABP | 1.46e-04 | 4 | 93 | 2 | IPR023341 | |
| Domain | MABP | 1.46e-04 | 4 | 93 | 2 | PS51498 | |
| Domain | - | 1.72e-04 | 22 | 93 | 3 | 2.130.10.30 | |
| Domain | Pentatricopeptide_repeat | 1.97e-04 | 23 | 93 | 3 | IPR002885 | |
| Domain | RCC1/BLIP-II | 1.97e-04 | 23 | 93 | 3 | IPR009091 | |
| Domain | PPR | 6.74e-04 | 8 | 93 | 2 | PS51375 | |
| Domain | Growth_fac_rcpt_ | 1.10e-03 | 156 | 93 | 5 | IPR009030 | |
| Domain | Inhibin_asu | 1.85e-03 | 13 | 93 | 2 | IPR002405 | |
| Domain | uDENN | 2.15e-03 | 14 | 93 | 2 | SM00800 | |
| Domain | uDENN | 2.47e-03 | 15 | 93 | 2 | PF03456 | |
| Domain | SAM/pointed | 2.78e-03 | 117 | 93 | 4 | IPR013761 | |
| Domain | UDENN | 2.81e-03 | 16 | 93 | 2 | PS50946 | |
| Domain | DDENN | 2.81e-03 | 16 | 93 | 2 | PS50947 | |
| Domain | DENN | 2.81e-03 | 16 | 93 | 2 | SM00799 | |
| Domain | dDENN | 2.81e-03 | 16 | 93 | 2 | SM00801 | |
| Domain | DENN | 2.81e-03 | 16 | 93 | 2 | PF02141 | |
| Domain | dDENN_dom | 2.81e-03 | 16 | 93 | 2 | IPR005112 | |
| Domain | uDENN_dom | 2.81e-03 | 16 | 93 | 2 | IPR005113 | |
| Domain | dDENN | 2.81e-03 | 16 | 93 | 2 | PF03455 | |
| Domain | DENN | 2.81e-03 | 16 | 93 | 2 | PS50211 | |
| Domain | DENN_dom | 2.81e-03 | 16 | 93 | 2 | IPR001194 | |
| Domain | RCC1 | 4.40e-03 | 20 | 93 | 2 | PF00415 | |
| Domain | Ank_2 | 4.42e-03 | 215 | 93 | 5 | PF12796 | |
| Domain | RCC1_1 | 4.84e-03 | 21 | 93 | 2 | PS00625 | |
| Domain | RCC1_2 | 4.84e-03 | 21 | 93 | 2 | PS00626 | |
| Domain | RCC1_3 | 4.84e-03 | 21 | 93 | 2 | PS50012 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 SH2B3 MYCBP2 GRIN2D HDAC7 WDR59 TRAK1 JAK3 RPAP1 MEGF8 SLC25A39 SCN5A HERC1 NOTCH2 RASAL1 ARHGAP33 BAHCC1 | 1.05e-08 | 1105 | 97 | 17 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A TTC28 MYCBP2 GIGYF1 CBL HDAC7 WDR59 TRAK1 MEGF8 STARD9 TJP2 GNAS GOLGB1 NOTCH2 | 1.22e-07 | 861 | 97 | 14 | 36931259 |
| Pubmed | TTC28 GON4L FAM91A1 TRAK1 KIDINS220 RPAP1 MEGF8 STARD9 DENND4B ANKRD12 | 2.19e-07 | 407 | 97 | 10 | 12693553 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30541061 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12906859 | ||
| Pubmed | The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells. | 2.31e-05 | 3 | 97 | 2 | 20086179 | |
| Pubmed | Cell adhesion to ephrinb2 is induced by EphB4 independently of its kinase activity. | 2.31e-05 | 3 | 97 | 2 | 15358160 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28611190 | ||
| Pubmed | Methylation alterations at imprinted genes detected among long-term shiftworkers. | 2.31e-05 | 3 | 97 | 2 | 23193016 | |
| Pubmed | Extracellular matrix mechanical cues regulate lipid metabolism through Lipin-1 and SREBP. | 2.31e-05 | 3 | 97 | 2 | 30718857 | |
| Pubmed | The formation and function of the cardiac conduction system. | 2.70e-05 | 21 | 97 | 3 | 26786210 | |
| Pubmed | 4.08e-05 | 24 | 97 | 3 | 21633169 | ||
| Pubmed | p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. | 4.60e-05 | 4 | 97 | 2 | 12080043 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 16819553 | ||
| Pubmed | mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. | 4.60e-05 | 4 | 97 | 2 | 21816276 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 29306897 | ||
| Pubmed | Threshold Levels of Gfi1 Maintain E2A Activity for B Cell Commitment via Repression of Id1. | 4.60e-05 | 4 | 97 | 2 | 27467586 | |
| Pubmed | 5.34e-05 | 73 | 97 | 4 | 22094256 | ||
| Pubmed | Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. | 7.29e-05 | 29 | 97 | 3 | 21909115 | |
| Pubmed | 8.61e-05 | 504 | 97 | 8 | 34432599 | ||
| Pubmed | 8.72e-05 | 650 | 97 | 9 | 38777146 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 24166977 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 1.31e-04 | 536 | 97 | 8 | 15840001 | |
| Pubmed | 1.35e-04 | 538 | 97 | 8 | 10512203 | ||
| Pubmed | 1.52e-04 | 285 | 97 | 6 | 34369648 | ||
| Pubmed | 2.59e-04 | 446 | 97 | 7 | 24255178 | ||
| Pubmed | 2.70e-04 | 449 | 97 | 7 | 31732153 | ||
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 9045636 | ||
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 23374343 | ||
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 26897459 | ||
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 22284677 | ||
| Pubmed | Mechanism Sharing Between Genetic and Gestational Hypoxia-Induced Cardiac Anomalies. | 4.17e-04 | 11 | 97 | 2 | 30151366 | |
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 4.67e-04 | 229 | 97 | 5 | 19948975 | |
| Pubmed | 4.99e-04 | 12 | 97 | 2 | 8621719 | ||
| Pubmed | p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis. | 4.99e-04 | 12 | 97 | 2 | 26527653 | |
| Pubmed | 5.52e-04 | 57 | 97 | 3 | 24952745 | ||
| Pubmed | 5.89e-04 | 13 | 97 | 2 | 11239002 | ||
| Pubmed | Mapping of the syndecan genes in the mouse: linkage with members of the myc gene family. | 5.89e-04 | 13 | 97 | 2 | 7959737 | |
| Pubmed | 6.85e-04 | 14 | 97 | 2 | 15601857 | ||
| Pubmed | 6.85e-04 | 14 | 97 | 2 | 17766470 | ||
| Pubmed | 6.85e-04 | 14 | 97 | 2 | 14757642 | ||
| Pubmed | 7.58e-04 | 255 | 97 | 5 | 15324660 | ||
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 7.89e-04 | 15 | 97 | 2 | 31285543 | |
| Pubmed | 7.89e-04 | 15 | 97 | 2 | 16601135 | ||
| Pubmed | 8.71e-04 | 263 | 97 | 5 | 34702444 | ||
| Pubmed | 9.01e-04 | 16 | 97 | 2 | 20007915 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 9.22e-04 | 719 | 97 | 8 | 35337019 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TTC28 MYCBP2 AHCTF1 DGKE TRMT2B TRAK1 SPATS2L RPAP1 GNAS HERC1 GOLGB1 SPRYD4 | 9.34e-04 | 1496 | 97 | 12 | 32877691 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 9.98e-04 | 908 | 97 | 9 | 19274049 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.05e-03 | 565 | 97 | 7 | 25468996 | |
| Pubmed | 1.08e-03 | 276 | 97 | 5 | 28319085 | ||
| Pubmed | TTC28 AHCTF1 DGKE GIGYF1 FCSK SCN5A NOTCH2 ARHGAP33 TP73 BAHCC1 | 1.12e-03 | 1116 | 97 | 10 | 31753913 | |
| Pubmed | 1.14e-03 | 18 | 97 | 2 | 18093989 | ||
| Pubmed | 1.14e-03 | 18 | 97 | 2 | 17702963 | ||
| Pubmed | Vegfa regulates perichondrial vascularity and osteoblast differentiation in bone development. | 1.14e-03 | 18 | 97 | 2 | 25977369 | |
| Pubmed | PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. | 1.14e-03 | 18 | 97 | 2 | 21511879 | |
| Pubmed | 1.14e-03 | 18 | 97 | 2 | 27180262 | ||
| Pubmed | 1.24e-03 | 285 | 97 | 5 | 32838362 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 1.25e-03 | 754 | 97 | 8 | 33060197 | |
| Pubmed | 1.28e-03 | 76 | 97 | 3 | 27542412 | ||
| Pubmed | Asb2α-Filamin A Axis Is Essential for Actin Cytoskeleton Remodeling During Heart Development. | 1.28e-03 | 19 | 97 | 2 | 29374072 | |
| Pubmed | 1.28e-03 | 19 | 97 | 2 | 16697675 | ||
| Pubmed | A Positive Regulatory Feedback Loop between EKLF/KLF1 and TAL1/SCL Sustaining the Erythropoiesis. | 1.28e-03 | 19 | 97 | 2 | 34360789 | |
| Pubmed | Genome-wide association study of blood pressure and hypertension. | 1.28e-03 | 19 | 97 | 2 | 19430479 | |
| Pubmed | GATA6 is a regulator of sinus node development and heart rhythm. | 1.42e-03 | 20 | 97 | 2 | 33443158 | |
| Pubmed | Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. | 1.42e-03 | 20 | 97 | 2 | 23314057 | |
| Pubmed | 1.42e-03 | 20 | 97 | 2 | 31591574 | ||
| Pubmed | 1.56e-03 | 21 | 97 | 2 | 17303760 | ||
| Pubmed | Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit. | 1.56e-03 | 21 | 97 | 2 | 28302382 | |
| Pubmed | 1.57e-03 | 606 | 97 | 7 | 36538041 | ||
| Pubmed | 1.71e-03 | 22 | 97 | 2 | 21507922 | ||
| Pubmed | A systematic survey of carbonic anhydrase mRNA expression during mammalian inner ear development. | 1.71e-03 | 22 | 97 | 2 | 23233153 | |
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 1.86e-03 | 460 | 97 | 6 | 20562862 | |
| Pubmed | 1.87e-03 | 23 | 97 | 2 | 14522948 | ||
| Pubmed | Hand2 is an essential regulator for two Notch-dependent functions within the embryonic endocardium. | 2.04e-03 | 24 | 97 | 2 | 25497097 | |
| Pubmed | 2.12e-03 | 322 | 97 | 5 | 26514267 | ||
| Pubmed | Regulatory pathway analysis by high-throughput in situ hybridization. | 2.14e-03 | 91 | 97 | 3 | 17953485 | |
| Pubmed | Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. | 2.22e-03 | 25 | 97 | 2 | 21829393 | |
| Pubmed | 2.40e-03 | 26 | 97 | 2 | 35961308 | ||
| Pubmed | 2.40e-03 | 26 | 97 | 2 | 32467237 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 2.42e-03 | 95 | 97 | 3 | 29643511 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 2.49e-03 | 1038 | 97 | 9 | 26673895 | |
| Pubmed | 2.64e-03 | 98 | 97 | 3 | 34943047 | ||
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 DENND4A PHF20 SH2B3 MYCBP2 DGKE IGFLR1 ZNF831 CBL GFI1 JAK3 LPIN1 KIDINS220 DENND4B GNAS HERC1 ARHGAP45 TAP1 NOTCH2 | 1.98e-06 | 1492 | 97 | 19 | M40023 |
| Coexpression | GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP | 7.22e-06 | 191 | 97 | 7 | M7130 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.47e-07 | 196 | 97 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.42e-06 | 176 | 97 | 6 | 9c1f255de3082b3da4bef2a9bdff710cfd48261f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.54e-06 | 188 | 97 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.61e-06 | 195 | 95 | 8 | 5008_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.68e-06 | 196 | 95 | 8 | 3271_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.68e-06 | 196 | 95 | 8 | 4724_UP | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.74e-06 | 197 | 95 | 8 | 4583_DN | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; HL60; HG-U133A | 1.88e-06 | 199 | 95 | 8 | 1425_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 1.61e-05 | 192 | 95 | 7 | 2699_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.78e-05 | 195 | 95 | 7 | 4975_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.78e-05 | 195 | 95 | 7 | 5579_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 4594_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 4972_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 6019_DN | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 3986_DN | |
| Drug | Atracurium besylate [64228-81-5]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 7477_UP | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 1463_UP | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 4555_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.09e-04 | 180 | 95 | 6 | 7420_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.23e-04 | 184 | 95 | 6 | 4994_UP | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.42e-04 | 189 | 95 | 6 | 2832_UP | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A | 1.51e-04 | 191 | 95 | 6 | 7542_UP | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.60e-04 | 193 | 95 | 6 | 5273_UP | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A | 1.60e-04 | 193 | 95 | 6 | 5289_DN | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.60e-04 | 193 | 95 | 6 | 3440_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 2430_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 7523_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 7538_DN | |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 2795_UP | |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 4740_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; PC3; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 7393_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 6052_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 2961_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 4570_DN | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 3793_UP | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 4987_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 2312_DN | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.74e-04 | 196 | 95 | 6 | 3331_UP | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3504_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3192_UP | |
| Drug | Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3551_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 5459_DN | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 5069_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3425_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4222_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4079_DN | |
| Drug | Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 7476_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 5703_UP | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 6100_DN | |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4842_DN | |
| Drug | Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; HL60; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 2944_UP | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 5410_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4690_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4570_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 6063_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 1648_UP | |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3441_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 5422_UP | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 4569_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 6957_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 1522_UP | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 6763_UP | |
| Drug | Ronidazole [7681-76-7]; Up 200; 20uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3557_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 1340_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3393_UP | |
| Drug | DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 2877_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 1466_UP | |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 7433_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 1502_UP | |
| Drug | rotenone; Down 200; 1uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 5915_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 3345_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 3224_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 1482_UP | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 1472_UP | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 2882_UP | |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 3616_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 4346_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 7019_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; HL60; HG-U133A | 1.88e-04 | 199 | 95 | 6 | 1390_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 5604_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.88e-04 | 199 | 95 | 6 | 1_UP | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 2214_DN | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 6218_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 4775_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 6049_DN | |
| Drug | atrial peptide | 2.91e-04 | 31 | 95 | 3 | CID005490906 | |
| Disease | Atrial standstill | 9.00e-06 | 2 | 89 | 2 | C0541782 | |
| Disease | Juvenile Myelomonocytic Leukemia | 2.48e-05 | 19 | 89 | 3 | C0349639 | |
| Disease | CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE | 2.69e-05 | 3 | 89 | 2 | C1838539 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.54e-05 | 61 | 89 | 4 | C1961102 | |
| Disease | breast cancer, COVID-19 | 3.92e-05 | 22 | 89 | 3 | MONDO_0007254, MONDO_0100096 | |
| Disease | CXCL11 measurement | 8.94e-05 | 5 | 89 | 2 | EFO_0010779 | |
| Disease | Anoxemia | 1.36e-04 | 33 | 89 | 3 | C0003129 | |
| Disease | Hypoxemia | 1.36e-04 | 33 | 89 | 3 | C0700292 | |
| Disease | Hypoxia | 1.36e-04 | 33 | 89 | 3 | C0242184 | |
| Disease | Anoxia | 1.36e-04 | 33 | 89 | 3 | C0003130 | |
| Disease | lymphocyte percentage of leukocytes | 1.82e-04 | 665 | 89 | 9 | EFO_0007993 | |
| Disease | cancer antigen 15.3 measurement | 1.87e-04 | 7 | 89 | 2 | EFO_0010585 | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 1.87e-04 | 7 | 89 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | EPHB4 INHBE XIRP1 SREBF2 DGKE GRIN2D HDAC7 THBS3 GOLGB1 NOTCH2 TP73 | 3.85e-04 | 1074 | 89 | 11 | C0006142 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.42e-04 | 49 | 89 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | DENND4A SH2B3 TTC28 GON4L GIGYF1 HDAC7 THBS3 KLF1 ANKRD12 LY75 GOLGB1 | 4.89e-04 | 1105 | 89 | 11 | EFO_0004528 |
| Disease | colorectal cancer (is_implicated_in) | 5.02e-04 | 121 | 89 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Hematologic Neoplasms | 5.82e-04 | 12 | 89 | 2 | C0376545 | |
| Disease | CCL2 measurement | 5.85e-04 | 126 | 89 | 4 | EFO_0004749 | |
| Disease | N-acetyl-isoputreanine measurement | 6.87e-04 | 13 | 89 | 2 | EFO_0800107 | |
| Disease | C-X-C motif chemokine 11 measurement | 8.00e-04 | 14 | 89 | 2 | EFO_0008057 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 8.00e-04 | 14 | 89 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | platelet-to-lymphocyte ratio | 8.20e-04 | 363 | 89 | 6 | EFO_0008446 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.44e-04 | 139 | 89 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | neutrophil count | PRUNE2 DENND4A SH2B3 TTC28 MYCBP2 TMEM235 KIDINS220 SLC4A4 LY75 ACKR1 ARHGAP45 NOTCH2 | 8.97e-04 | 1382 | 89 | 12 | EFO_0004833 |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 9.21e-04 | 15 | 89 | 2 | C2930967 | |
| Disease | Leukemia, Myelocytic, Acute | 1.89e-03 | 173 | 89 | 4 | C0023467 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 2.00e-03 | 22 | 89 | 2 | C1843687 | |
| Disease | nephrosis (biomarker_via_orthology) | 2.00e-03 | 22 | 89 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | urinary albumin to creatinine ratio | 2.14e-03 | 179 | 89 | 4 | EFO_0007778 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 2.19e-03 | 85 | 89 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | neutrophil percentage of leukocytes | 2.49e-03 | 610 | 89 | 7 | EFO_0007990 | |
| Disease | platelet measurement | 2.68e-03 | 315 | 89 | 5 | EFO_0005036 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASGLHWSSLDSPVGS | 51 | P84996 | |
| ALGRGPWDSSDRSAL | 96 | P01160 | |
| DHFLGRRGSPLLSWS | 2116 | Q9P281 | |
| WELEVAGLGSDPHLS | 146 | Q6UXG8 | |
| EHALRRTPSWSSLGG | 6 | Q9UGI9 | |
| GLDPLGSSETLWSHR | 186 | Q8N9P6 | |
| LPEGWSSHLDTLGSK | 321 | Q16570 | |
| DPGHTSENWGERLIS | 81 | Q6UB98 | |
| LHTLSDTLWGPGDSR | 356 | Q16790 | |
| GATDSLGLEWHLPSP | 1616 | Q7Z401 | |
| RTHSAVTLGDWSDPL | 706 | O95294 | |
| PHSSLRELLATCWDG | 446 | P52333 | |
| GTDGLWTDPHRSDLQ | 141 | Q96DU7 | |
| TLGGPEHSVLDLWRT | 386 | Q4KMZ1 | |
| HGSLWLPEGFTLRRD | 1706 | Q04721 | |
| LRDSWGGTPLHDAAE | 266 | Q6ZVH7 | |
| LGLDEGAPRHSNLSW | 1336 | Q9ULH0 | |
| GAASWTLGRSHRSPL | 81 | Q92619 | |
| SLSVPDSGRLWDVHT | 636 | O75420 | |
| GSSLHLEWSAPLESG | 336 | P54760 | |
| PYSWSGLAGSDLRHL | 121 | Q99684 | |
| FIEHLPGRLWEGSTS | 106 | O95998 | |
| SYDRLLITSWGHDPG | 566 | Q658Y4 | |
| GTSHSLAWTALPRDR | 726 | Q15751 | |
| GGLELWHGTSSLDIA | 216 | O95972 | |
| DGAVGSRTLHWDTDP | 106 | Q13409 | |
| LGWHTLTLPSSGLRG | 166 | P58166 | |
| LSALPAVGWHDTSER | 141 | Q6NV75 | |
| RGGPSDHEATAWILI | 216 | Q8WX77 | |
| GHSELTLLWDRTGVP | 816 | Q7Z7M0 | |
| HPTRLGWQEFGLSTD | 1226 | Q5T7B8 | |
| SDTLGHILPTLGKDW | 686 | Q14693 | |
| PLWVGLSSHDGSESS | 1451 | O60449 | |
| RSGTGLTPLHWAAAL | 136 | E5RJM6 | |
| DGTSWTLLGLPAVSH | 306 | Q9P2V4 | |
| HRDGNTLPSPSSWDL | 551 | Q86Y26 | |
| GGTTFEHLWSSLEPD | 11 | O15350 | |
| LSGSPSHRTSAWLDD | 706 | O14559 | |
| GSIGRSLPHITDVSW | 116 | Q9UBI1 | |
| WSELPHGSGLGTSSI | 831 | Q8N0W3 | |
| RATSGLTLWPHTAEG | 186 | Q9UFP1 | |
| LTLWPHTAEGRDLLG | 191 | Q9UFP1 | |
| DLALTPLAGEGHTRW | 146 | Q6U949 | |
| LLGSEDHSGWVRPAL | 126 | Q13351 | |
| HLSSPGALETGDTWK | 216 | Q9H665 | |
| DLSSVSLSWDPSHGR | 41 | Q3T8J9 | |
| ALVGDPGTDHLIRWS | 26 | Q9ULV5 | |
| TGHSWADALSTIRLP | 36 | O95372 | |
| RGSPVPWHDGSLSDL | 991 | O75064 | |
| PWHDGSLSDLSLTGE | 996 | O75064 | |
| SDPWTGRELTNRHSL | 606 | P22681 | |
| LWFSHSGLLPEGIDD | 671 | Q8WYP5 | |
| SPSEGLFADGHLILW | 11 | P52429 | |
| TERLSGSGLHWPLSR | 341 | Q8WUI4 | |
| GSGLHWPLSRTRSEP | 346 | Q8WUI4 | |
| DHYLTLRSSGWIPDG | 191 | Q9BWG6 | |
| TTHGALLSGWREADR | 481 | Q6QHF9 | |
| LHENGDDSLSPRLGW | 871 | Q9BVI0 | |
| GLESLHVWLSIPFGS | 21 | Q8NGK5 | |
| SHLGPLDGSWQERLA | 71 | Q96GJ1 | |
| REHSIDGTGWAPTRT | 121 | Q969M7 | |
| LIEDFASLWHSGRSP | 761 | Q8WUY3 | |
| PAFALWDGELLTHSG | 186 | Q8WW59 | |
| STHLGLTLLWDGGTR | 1116 | A2VEC9 | |
| TALEEHWLRDPTGLS | 4551 | A2VEC9 | |
| PIHGTTERSDGLQWS | 166 | Q9NUQ6 | |
| SYDRLLITSWGHDPG | 211 | P0C866 | |
| GLEHPIGSSEWLLSA | 3361 | Q96Q15 | |
| SELRDSDSGLLPRWH | 866 | Q14524 | |
| APGSADSTRLLHWGS | 121 | Q03518 | |
| LDSRHIGWVTSELPG | 3831 | O75592 | |
| RTLDRPSSWGGLQHL | 4071 | Q9P2P6 | |
| GLVRESHPSLSPASW | 201 | A6NNN8 | |
| TDRDPWHPLSDGSRT | 176 | Q96GD0 | |
| PQSWDRAGRGSLLHS | 756 | Q9UPV9 | |
| LGSVALHLSWGPTER | 136 | Q8TCV5 | |
| DIPRTWATAGLHIGD | 76 | A6NM28 | |
| LNSHGGRSRSWEDSP | 161 | Q9UDY2 | |
| NGSAWPGRAELLSSH | 41 | A6NFC5 | |
| PGRAELLSSHSGLWR | 46 | A6NFC5 | |
| RHEGTRTLWSGLPAT | 116 | Q9BZJ4 | |
| WLSRHTEAAPGDSGL | 321 | Q9BW04 | |
| VADGSLHPSAELWSP | 216 | P15923 | |
| SELNPAGSSWLHVGT | 971 | Q7Z6L1 | |
| PLTSLLQWGGAHDSD | 496 | Q12772 | |
| HWGSELGLPHLSSSG | 491 | Q9UQQ2 | |
| LSQPTLGSLWDSLRH | 836 | Q9BWH6 | |
| TSVSGPGEHLRNALW | 836 | P49746 | |
| IAGREAEHLSSPWGE | 806 | Q6PJI9 | |
| NGHWRTETTSLGSLP | 2431 | Q96AY4 | |
| LALLSSLGSWHGAED | 41 | Q8NEK5 | |
| SSGKHLEWLRAPGTL | 316 | Q9P272 | |
| GGERWSKPHVATLSL | 141 | Q9Y6R1 | |
| LFEIGSHSPSSWGSL | 36 | Q9BXG8 | |
| GWPELALSSHSGTSR | 1146 | Q5JPB2 | |
| LAWVSTHTAEGGDPL | 26 | Q9BVT8 | |
| RPGELWHFSSLAGTS | 126 | Q99990 | |
| WHFSSLAGTSSLEPG | 131 | Q99990 | |
| GDLSGLHSLRWEPPA | 936 | Q702N8 | |
| LSSSHPWGPRTLGLE | 306 | Q96RL6 | |
| SDSEVWLDSHLGSPG | 126 | P17097 | |
| DWVSRGESVGLHLPT | 16 | A0A0B4J235 | |
| LEHSEWDSSRTPIIG | 3181 | Q14789 | |
| SLVGWEHRGALTLDP | 211 | O15399 |